详情页 - 四川省肿瘤医院知识库

资源类型：

文章类型：

作者：

Huang, Jing[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] *

; Song, Yan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Kou, Xiaoge[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Tan, Zhenbo[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhang, Shu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Sun, Meili[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhou, Jin[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]

; Fan, Min[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhang, Ming[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Song, Yongxiang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Li, Suyi[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Yuan, Yuan[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhuang, Wu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhang, Jingdong[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhang, Li[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]

; Jiang, Hao[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]

; Gu, Kangsheng[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Ye, Huangyang[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Wang, Qingyu[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18] ; Zhu, Jun[1,2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18]

;

机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [2]Xinxiang Med Univ, Affiliated Hosp, Xinxiang, Peoples R China [3]Xingtai Peoples Hosp, Xingtai, Peoples R China [4]Shandong First Med Univ, Shandong Canc Hosp, Canc Hosp, Jinan, Peoples R China [5]Shandong First Med Univ, Cent Hosp Affiliated, Jinan, Peoples R China [6]Sichuan Canc Hosp, Chengdu, Peoples R China [7]Fudan Univ Shanghai, Canc Ctr, Shanghai, Peoples R China [8]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China [9]Zunyi Med Univ, Affiliated Hosp, Zunyi, Peoples R China [10]Anhui Prov Canc Hosp, Hefei, Peoples R China [11]Xuzhou Cent Hosp, Xuzhou, Peoples R China [12]Fujian Canc Hosp, Fuzhou, Peoples R China [13]China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Shenyang, Peoples R China [14]Chongqing Univ, Three Gorges Hosp, Chongqing, Peoples R China [15]Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China [16]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [17]Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China [18]Shanghai Henlius Biotech Inc, Shanghai, Peoples R China

出处：

ISSN：

基金：

语种：

WOS：

中科院(CAS)分区：

出版当年[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区肿瘤学

JCR分区：

出版当年[2023]版：

Q1 ONCOLOGY

最新[2023]版：

Q1 ONCOLOGY

第一作者：

第一作者机构： [1]Chinese Acad Med Sci & Peking Union Med Coll, Natl Canc Ctr, Natl Clin Res Ctr Canc, Canc Hosp, Beijing, Peoples R China [2]Xinxiang Med Univ, Affiliated Hosp, Xinxiang, Peoples R China [3]Xingtai Peoples Hosp, Xingtai, Peoples R China [4]Shandong First Med Univ, Shandong Canc Hosp, Canc Hosp, Jinan, Peoples R China [5]Shandong First Med Univ, Cent Hosp Affiliated, Jinan, Peoples R China [6]Sichuan Canc Hosp, Chengdu, Peoples R China [7]Fudan Univ Shanghai, Canc Ctr, Shanghai, Peoples R China [8]Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Shanghai, Peoples R China [9]Zunyi Med Univ, Affiliated Hosp, Zunyi, Peoples R China [10]Anhui Prov Canc Hosp, Hefei, Peoples R China [11]Xuzhou Cent Hosp, Xuzhou, Peoples R China [12]Fujian Canc Hosp, Fuzhou, Peoples R China [13]China Med Univ, Liaoning Canc Hosp & Inst, Canc Hosp, Shenyang, Peoples R China [14]Chongqing Univ, Three Gorges Hosp, Chongqing, Peoples R China [15]Bengbu Med Coll, Affiliated Hosp 1, Bengbu, Peoples R China [16]Anhui Med Univ, Affiliated Hosp 1, Hefei, Peoples R China [17]Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China [18]Shanghai Henlius Biotech Inc, Shanghai, Peoples R China

推荐引用方式(GB/T 7714)：

APA：

MLA：

Updated results of first-line serplulimab versus placebo plus chemotherapy in PD-L1-positive esophageal squamous cell carcinoma: A randomized, double-blind, multicenter phase 3 study (ASTRUM-007)

文献详情